Importantly, we found that disulfiram could ameliorate chronic prostatitis by inhibiting GSDMD-NT-mediated prostate epithelial cell pyroptosis and Th17 cell differentiation, and targeting P2X7R and pyroptosis may be effective in chronic prostatitis treatment. The gene discussed is GSDMD; the disease is chronic prostatitis.